Candidiasis Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

CANDIDIASIS MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Candidiasis Market Overview
Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus,
which is present in the human body. It is usually present in places like mouth, belly, and on the
skin. The overgrowth of these leads to an infection. This dormant yeast can lead to candida
infection at any stage in a person’s life and is closely linked to the immunity level of the person.
There are various types of infections caused due to candidiasis, such as thrush/ oropharyngeal
candidiasis, genital yeast infection/ invasive infection, and cutaneous candidiasis. Thrush/
oropharyngeal candidiasis affects the mouth or throat; genital yeast infection affects the vagina;
and cutaneous candidiasis is the infection of the skin. When the infection enters into the blood
stream, the condition is called Candidemia. Candidiasis can be diagnosed by physical
observation. These conditions are usually treated using over-the-counter antifungal medicines
and also specific prescription-based antifungal medicines.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/229
Increasing consumer awareness about candidiasis and growing number of treatment options are
major factors fueling growth of the candidiasis market. Conversely, dearth of R&D activities, low
product availability, and easy access to alternative treatment methods such as use of herbal
medicines inhibits growth of the candidiasis market.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Rising awareness regarding the infection and increasing patient pool to favor the growth of
Candidiasis market
Rising awareness about the infections is expected to cause the growth of candidiasis market. Increasing
focus of various governments in the APAC region, such as in highly populous China and India, on
improving the healthcare infrastructure, along with increasing consumer awareness about the condition
is expected to position the region on a high growth trajectory in the global candidiasis industry over the
forecast period (2016–2024). Candidiasis are treated using various treatment option such as oral
medication, injection, and ointments. Candidiasis can infect males, females and also newborn babies.
The condition is notoriously hard to treat in people suffering from diabetes, cancer, AIDS, and also
pregnant women. As per stats released by Centers for Disease Control and Prevention (CDC), around
75% of would suffer from at least one vaginal candida infection in their whole life, while 40-45% would
suffer twice or more. Furthermore, 46,000 cases of invasive candidiasis are reported each year in the
U.S. High costs of antifungal drugs and also the poor results of these drugs inhibit market growth,
especially in cost-sensitive emerging economies. Invasive candida infection is associated with high rates
of morbidity and mortality. According to the Centers for Disease Control and Prevention (CDC), mortality
rate is 19-24%, though these are not entirely accurate figures, these people usually suffer from other
medical conditions as well.
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/229
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Developed Regions Growth Engine of Candidiasis Market
In developed countries, increasing number of organ transplantation, use of catheters, artificial
valves, and joints causing to growth of candida infection. The North America and Europe regions
account for the largest market share, due to high awareness about the infection, wide
availability of treatment and easy access to OTC antifungal drugs creates a highly conducive
environment for growth of the market. Azole Drugs holds large market share, with products
such as Vfend, Noxafil, and Diflucan being highly preferred among the masses. In December
2016, Lupin Ltd. launched Voriconazole Tablets, 50 mg & 200 mg and Voriconazole Oral
Suspension, 40 mg/mL as substitutes for PF Prism C.V’s Vfend Tablets, 50 mg & 200 mg and
Vfend Oral Suspension, 40 mg/mL. PF Prism C.V holds a patent for its highly effective Vfend
drug. Allylamines drugs are expected to experience a positive growth curve in the near future,
with various products in the pipeline. These drugs plays an important role in preventing skin
infection. The Polyene segment growth is not positive due to absence of new product
development in the recent past and also wide availability of generic substitutes.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/229
The major market players in Candidiasis market are Bayer, Teva Pharmaceuticals, Stellar
Pharma, Pfizer, Wockhardt, Glenmark Pharmaceuticals, Ranbaxy, Taro Pharmaceuticals, and
Bristol Laboratories, among others.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which is present in the human body. It is usually present in places like mouth, belly, and on the skin. The overgrowth of these leads to an infection. This dormant yeast can lead to candida infection at any stage in a person’s life and is closely linked to the immunity level of the person. There are various types of infections caused due to candidiasis, such as thrush/ oropharyngeal candidiasis, genital yeast infection/ invasive infection, and cutaneous candidiasis. Thrush/ oropharyngeal candidiasis affects the mouth or throat; genital yeast infection affects the vagina; and cutaneous candidiasis is the infection of the skin. When the infection enters into the blood stream, the condition is called Candidemia. Candidiasis can be diagnosed by physical observation. These conditions are usually treated using over-the-counter antifungal medicines and also specific prescription-based antifungal medicines. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/229